Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial

R.E. van Genugten, D.H. van Raalte, M.H.A. Muskiet, M.W. Heymans, P.J.W. Pouwels, D.M. Ouwens, A. Mari, M. Diamant

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)429-439
JournalEuropean Journal of Endocrinology
Issue number3
Publication statusPublished - 2014

Cite this